Basic Information
Cartridge Based Nucleic Acid Amplification Test (CBNAAT) : A Rapid cost effective RT-PCR for common infectious diseases & HLA B27
While RT-PCR has provided a sensitive and specific "quantum leap" in diagnosing infectious diseases over the last decade, it historically faced hurdles. Traditional molecular diagnostics often struggled with contamination, reagent stability, and lack of standardization, limiting their overall clinical utility. Furthermore, testing was largely restricted to large chain laboratories. To maintain affordability, these labs relied on batch testing, which significantly increased turn-around times (TAT) and delayed critical patient care decisions. The introduction of CB-NAAT (Cartridge Based Nucleic Acid Amplification Test) has been a game-changer. By integrating sample preparation and analysis into a sophisticated, closed system, it offers the precision of high-end RT-PCR while eliminating the risks of manual error and contamination. Realizing this potential, North Delhi Pathology Clinic has adopted CB-NAAT technology. This allows the clinic to deliver reliable, clinically validated results in just a few hours, providing patients with fast, cost-effective, and highly accurate molecular diagnostics.
Available CB-NAAT - RT PCR tests M.tuberculosis with RIF Resistance Specimen:Site Specific
Pulmonary:Sputum & Bronchial Aspirate etc. Extra-pulmonary:Pus, Fluids, FNA, Biopsy etc.
Specimen: Cervical Swab Reporting: Same day New
Chlamydia/Neisseria
Qualitative
Specimen: Urethral/Cervical Swab, or Urine Reporting: Same day
* Not in NABL Scope